Cargando…

High-Risk Obesity Phenotypes: Target for Multimorbidity Prevention at the ROFEMI Study

Background: Describe the profile of patients with obesity in internal medicine to determine the role of adiposity and related inflammation on the metabolic risk profile and, identify various “high-risk obesity” phenotypes by means of a cluster analysis. This study aimed to identify different profile...

Descripción completa

Detalles Bibliográficos
Autores principales: Carretero-Gómez, Juana, Pérez-Martínez, Pablo, Seguí-Ripoll, José Miguel, Carrasco-Sánchez, Francisco Javier, Lois Martínez, Nagore, Fernández Pérez, Esther, Pérez Hernández, Onán, García Ordoñez, Miguel Ángel, Martín González, Candelaria, Vigueras-Pérez, Juan Francisco, Puchades, Francesc, Blasco Avaria, María Cristina, Pérez Soto, María Isabel, Ena, Javier, Arévalo-Lorido, José Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410284/
https://www.ncbi.nlm.nih.gov/pubmed/36012889
http://dx.doi.org/10.3390/jcm11164644
_version_ 1784775056004481024
author Carretero-Gómez, Juana
Pérez-Martínez, Pablo
Seguí-Ripoll, José Miguel
Carrasco-Sánchez, Francisco Javier
Lois Martínez, Nagore
Fernández Pérez, Esther
Pérez Hernández, Onán
García Ordoñez, Miguel Ángel
Martín González, Candelaria
Vigueras-Pérez, Juan Francisco
Puchades, Francesc
Blasco Avaria, María Cristina
Pérez Soto, María Isabel
Ena, Javier
Arévalo-Lorido, José Carlos
author_facet Carretero-Gómez, Juana
Pérez-Martínez, Pablo
Seguí-Ripoll, José Miguel
Carrasco-Sánchez, Francisco Javier
Lois Martínez, Nagore
Fernández Pérez, Esther
Pérez Hernández, Onán
García Ordoñez, Miguel Ángel
Martín González, Candelaria
Vigueras-Pérez, Juan Francisco
Puchades, Francesc
Blasco Avaria, María Cristina
Pérez Soto, María Isabel
Ena, Javier
Arévalo-Lorido, José Carlos
author_sort Carretero-Gómez, Juana
collection PubMed
description Background: Describe the profile of patients with obesity in internal medicine to determine the role of adiposity and related inflammation on the metabolic risk profile and, identify various “high-risk obesity” phenotypes by means of a cluster analysis. This study aimed to identify different profiles of patients with high-risk obesity based on a cluster analysis. Methods: Cross-sectional, multicenter project that included outpatients attended to in internal medicine. A total of 536 patients were studied. The mean age was 62 years, 51% were women. Patients were recruited from internal medicine departments over two weeks in November and December 2021 and classified into four risk groups according to body mass index (BMI) and waist circumference (WC). High-risk obesity was defined as BMI > 35 Kg/m(2) or BMI 30–34.9 Kg/m(2) and a high WC (>102 cm for men and >88 cm for women). Hierarchical and partitioning clustering approaches were performed to identify profiles. Results: A total of 462 (86%) subjects were classified into the high-risk obesity group. After excluding 19 patients missing critical data, two profiles emerged: cluster 1 (n = 396) and cluster 2 (n = 47). Compared to cluster 1, cluster 2 had a worse profile, characterized by older age (77 ± 16 vs. 61 ± 21 years, p < 0.01), a Charlson Comorbidity Index > 3 (53% vs. 5%, p < 0.001), depression (36% vs. 19%, p = 0.008), severe disability (64% vs. 3%, p < 0.001), and a sarcopenia score ≥ 4 (79% vs. 16%, p < 0.01). In addition, cluster 2 had greater inflammation than cluster 1 (hsCRP: 5.8 ± 4.1 vs. 2.1 ± 4.5 mg/dL, p = 0.008). Conclusions: Two profiles of subjects with high-risk obesity were identified. Based on that, older subjects with obesity require measures that target sarcopenia, disability, psychological health, and significant comorbidities to prevent further health deterioration. Longitudinal studies should be performed to identify potential risk factors of subjects who progress from cluster 1 to cluster 2.
format Online
Article
Text
id pubmed-9410284
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94102842022-08-26 High-Risk Obesity Phenotypes: Target for Multimorbidity Prevention at the ROFEMI Study Carretero-Gómez, Juana Pérez-Martínez, Pablo Seguí-Ripoll, José Miguel Carrasco-Sánchez, Francisco Javier Lois Martínez, Nagore Fernández Pérez, Esther Pérez Hernández, Onán García Ordoñez, Miguel Ángel Martín González, Candelaria Vigueras-Pérez, Juan Francisco Puchades, Francesc Blasco Avaria, María Cristina Pérez Soto, María Isabel Ena, Javier Arévalo-Lorido, José Carlos J Clin Med Article Background: Describe the profile of patients with obesity in internal medicine to determine the role of adiposity and related inflammation on the metabolic risk profile and, identify various “high-risk obesity” phenotypes by means of a cluster analysis. This study aimed to identify different profiles of patients with high-risk obesity based on a cluster analysis. Methods: Cross-sectional, multicenter project that included outpatients attended to in internal medicine. A total of 536 patients were studied. The mean age was 62 years, 51% were women. Patients were recruited from internal medicine departments over two weeks in November and December 2021 and classified into four risk groups according to body mass index (BMI) and waist circumference (WC). High-risk obesity was defined as BMI > 35 Kg/m(2) or BMI 30–34.9 Kg/m(2) and a high WC (>102 cm for men and >88 cm for women). Hierarchical and partitioning clustering approaches were performed to identify profiles. Results: A total of 462 (86%) subjects were classified into the high-risk obesity group. After excluding 19 patients missing critical data, two profiles emerged: cluster 1 (n = 396) and cluster 2 (n = 47). Compared to cluster 1, cluster 2 had a worse profile, characterized by older age (77 ± 16 vs. 61 ± 21 years, p < 0.01), a Charlson Comorbidity Index > 3 (53% vs. 5%, p < 0.001), depression (36% vs. 19%, p = 0.008), severe disability (64% vs. 3%, p < 0.001), and a sarcopenia score ≥ 4 (79% vs. 16%, p < 0.01). In addition, cluster 2 had greater inflammation than cluster 1 (hsCRP: 5.8 ± 4.1 vs. 2.1 ± 4.5 mg/dL, p = 0.008). Conclusions: Two profiles of subjects with high-risk obesity were identified. Based on that, older subjects with obesity require measures that target sarcopenia, disability, psychological health, and significant comorbidities to prevent further health deterioration. Longitudinal studies should be performed to identify potential risk factors of subjects who progress from cluster 1 to cluster 2. MDPI 2022-08-09 /pmc/articles/PMC9410284/ /pubmed/36012889 http://dx.doi.org/10.3390/jcm11164644 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Carretero-Gómez, Juana
Pérez-Martínez, Pablo
Seguí-Ripoll, José Miguel
Carrasco-Sánchez, Francisco Javier
Lois Martínez, Nagore
Fernández Pérez, Esther
Pérez Hernández, Onán
García Ordoñez, Miguel Ángel
Martín González, Candelaria
Vigueras-Pérez, Juan Francisco
Puchades, Francesc
Blasco Avaria, María Cristina
Pérez Soto, María Isabel
Ena, Javier
Arévalo-Lorido, José Carlos
High-Risk Obesity Phenotypes: Target for Multimorbidity Prevention at the ROFEMI Study
title High-Risk Obesity Phenotypes: Target for Multimorbidity Prevention at the ROFEMI Study
title_full High-Risk Obesity Phenotypes: Target for Multimorbidity Prevention at the ROFEMI Study
title_fullStr High-Risk Obesity Phenotypes: Target for Multimorbidity Prevention at the ROFEMI Study
title_full_unstemmed High-Risk Obesity Phenotypes: Target for Multimorbidity Prevention at the ROFEMI Study
title_short High-Risk Obesity Phenotypes: Target for Multimorbidity Prevention at the ROFEMI Study
title_sort high-risk obesity phenotypes: target for multimorbidity prevention at the rofemi study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410284/
https://www.ncbi.nlm.nih.gov/pubmed/36012889
http://dx.doi.org/10.3390/jcm11164644
work_keys_str_mv AT carreterogomezjuana highriskobesityphenotypestargetformultimorbiditypreventionattherofemistudy
AT perezmartinezpablo highriskobesityphenotypestargetformultimorbiditypreventionattherofemistudy
AT seguiripolljosemiguel highriskobesityphenotypestargetformultimorbiditypreventionattherofemistudy
AT carrascosanchezfranciscojavier highriskobesityphenotypestargetformultimorbiditypreventionattherofemistudy
AT loismartineznagore highriskobesityphenotypestargetformultimorbiditypreventionattherofemistudy
AT fernandezperezesther highriskobesityphenotypestargetformultimorbiditypreventionattherofemistudy
AT perezhernandezonan highriskobesityphenotypestargetformultimorbiditypreventionattherofemistudy
AT garciaordonezmiguelangel highriskobesityphenotypestargetformultimorbiditypreventionattherofemistudy
AT martingonzalezcandelaria highriskobesityphenotypestargetformultimorbiditypreventionattherofemistudy
AT viguerasperezjuanfrancisco highriskobesityphenotypestargetformultimorbiditypreventionattherofemistudy
AT puchadesfrancesc highriskobesityphenotypestargetformultimorbiditypreventionattherofemistudy
AT blascoavariamariacristina highriskobesityphenotypestargetformultimorbiditypreventionattherofemistudy
AT perezsotomariaisabel highriskobesityphenotypestargetformultimorbiditypreventionattherofemistudy
AT enajavier highriskobesityphenotypestargetformultimorbiditypreventionattherofemistudy
AT arevaloloridojosecarlos highriskobesityphenotypestargetformultimorbiditypreventionattherofemistudy
AT highriskobesityphenotypestargetformultimorbiditypreventionattherofemistudy